Summary The death certificate only (DCO) index, which quantifies the proportion of patients for whom the death certificate provides the only notification to the registry, is a widely used measure of incompleteness of population-based cancer registration. This paper provides an algebraic assessment and a quantitative illustration of the relationship between the DCO index and incompleteness of cancer registration. It is shown that the relationship between the DCO index and incompleteness of registration is strongly dependent on the case fatality rate and the misclassification rates of cancer deaths among unregistered patients. Therefore, the DCO index is a very poor indicator of incompleteness. Similar limitations apply to the DCN index (proportion of cases first notified by death certificate), which has been proposed as an alternative measure of incompleteness.
Population-based cancer registries are most valuable tools of both descriptive and analytical cancer epidemiology. Exhaustive ascertainment of all cases can rarely be achieved, however, on the population level. Therefore, attempts to quantify the degree of underascertainment are essential for proper interpretation of cancer registry data.
Various approaches have been proposed to quantify incompleteness of population-based cancer registration (Freedman, 1978; Goldberg et al., 1980; Benn et al., 1982; Devesa et al., 1984; Shanmugaratnam, 1989; Jensen et al., 1991; Parkin et al., 1992) . A particularly widely used indirect measure of incompleteness is the death certificate only index (DCO index) which quantifies the proportion of cases for whom the death certificate is the only source of notification. For example, the DCO index is routinely reported as an indicator of incompleteness in international cancer incidence statistics published by the International Agency for Research on Cancer (Parkin et al., 1992) .
One of the major reasons for the popularity of the DCO index is its ease of calculation in situations in which death certificates are routinely linked with registry data. Nevertheless, the DCO index has a variety of limitations, the best known being its dependence on case fatality rates: poor completeness may go along with a low DCO index for cancers which have low case fatality rates. Another major limitation of the DCO index is its sensitivity to the welldocumented inaccuracies of the certified causes of death (Barclay and Phillips, 1962; De Faire et al., 1976; Percy et al., 1981) . As an example, endometrial cancer is often misclassified as cervical cancer, and vice versa, on death certificates, and similar misclassification problems have also been documented for other cancers, such as colon and rectum cancer (Percy et al., 1981) . Furthermore, non-specific codes, such as cancer of unknown site, are frequently used on death certificates, and cancer often remains undetected as the underlying cause of death among elderly patients. While these limitations have been widely recognised, systematic quantitative work is lacking on their impact on the value of the DCO index as an indicator of incompleteness.
In the present paper, a simple algebraic framework is provided for such an assessment, and the relation between the DCO index and incompleteness of cancer registration is investigated as a function of its major determinants. The results are numerically illustrated for practically relevant ranges of values of these determinants. Unfortunately, there has been a lack of uniformity and some confusion in the use of the term 'death certificate only' and in reporting of cancer incidence data (Parkin et al., 1992) . A minority of cancer registries do not include DCO cases in tabulations of cancer incidence. Some cancer registries make efforts to get additional notifications from other sources when they receive a death certificate of a previously unnotified case. For example, an additional notification on the deceased individual is often requested from the doctor who fills out the death certificate. This strategy helps to obtain more comprehensive and accurate information on these patients. It has been argued that such 'secondary' notifications should be excluded when estimating completeness of cancer registration (Benn et al., 1982) , and an alternative index, the 'DCNindex' (proportion of cases first notified by death certificates) has been proposed to characterise incompleteness in such situations (Parkin et al., 1992) . The algebraic model provided in this paper is equally applicable to both the DCO index and the DCN index, but the main focus of the paper is on the DCO index, which is more frequently reported by cancer registries.
Definitions and algebraic framework Let DCO and INC denote the DCO index and the level of incompleteness of a registry respectively. DCO cases are assumed to be included in incidence calculations, and incompleteness is defined here as the proportion of cancer cases missed by both death certificates and notifications by other sources. Let P. be the probability of ascertainment of patients by sources other than the death certificate (diagnosed at life or post mortem), and let Pd be the probability of death due to the cancer of interest ('case fatality rate') among cancer patients for whom no notification other than the death certificate is made ('unregistered cases') respectively (if the model is applied to the DCN index, PO is defined as the probability that a primary notification is made by a source other than the death certificate and Pd is defined as the case fatality rate among patients for whom no such primary notification is made).
I will first address the relationship of DCO and INC with the individual ascertainment rates by death certificates and other sources that would be expected if both types of sources were free of diagnostic error. In addition, the following assumptions are made:
(1) Notifications through death certificates are complete among patients who die from cancer.
(2) PO and Pd are approximately stable over time.
Assumption (2) allows the time lag between diagnosis of (1) and (2):
or, equivalently, (5) and (6) Logan (1978) are highest for cancer of the pancreas (0.98), the liver (0.92), the lung (0.88) and the stomach (0.86). Case fatality rates are much lower for other cancers, such as endometrial cancer, and even more so for some cancers not listed in Table I , such as non-melanoma skin cancer, which has a case fatality rate close to zero. Rates of false-positive and false-negative diagnoses also show strong variation between cancer sites. In the study by Percy et al. (1981), misdiagnoses were rare for breast cancer. The highest rates of false-positive diagnoses were found for liver cancer (0.67, mostly because of frequent misclassification of liver metastases as primary liver cancer) and endometrial cancer (0.32, owing to frequent misclassification of cervical cancer), and the highest rate of false-negative diagnoses was found for rectum cancer (0.44, owing to frequent misclassification as colon cancer).
While previous studies including the examples given in Table I reflect case fatality and misclassification rates among registered patients or patients identified in cancer surveys, comprehensive quantitative studies of these rates among unregistered patients are lacking. It appears reasonable to assume that among unregistered patients, who are concentrated in the older age groups, both case fatality rates and misclassification rates of causes of death are higher than among other patients. Thus, the examples given in Table I should be regarded as providing lower limits of practically relevant values of the parameters of interest. Figure 1 illustrates the relationship between INC and the DCO index as a function of the case fatality rate Pd in unregistered patients (which is varied over a wide range between 0.05 and 0.90) that would be expected if classification of cancer deaths was perfect. The figure demonstrates the extreme dependency of the DCO index on Pd for given levels of INC and vice versa.
Only for cancers with a case fatality rate of about 40% among unregistered patients would the level of incompleteness approximately equal the value of the DCO index. Incompleteness would be much higher than the DCO index for cancers with lower case fatality rates, and much lower than the DCO index for cancers with higher case fatality rates among unregistered patients. For example, a DCO index of 0.05 would correspond to 0.6% incompleteness for a cancer with a case fatality rate of 90% among unregistered patients, but to almost 50% incompleteness for a cancer with a case fatality rate of 5% among unregistered patients.
Figures 2 and 3 illustrate the impact of false-negative and false-positive cancer diagnoses on the relationship between the DCO index and incompleteness of registration. f, and fp are varied between 0 and 0.50 to reflect a broad range of potentially relevant values. Figure 2 demonstrates the effects of false-negative diagnoses in the absence of false-positive diagnoses. It can be seen that the DCOindex very strongly decreases with the rate of false-negative diagnoses for given values of INC and Pd. Thus, DCO rates can be deceptively low even for highly fatal cancers if the rate of false-negative diagnoses is high.
Opposite effects are expected from false-positive diagnoses in the absence of false negative diagnoses (Figure 3 ). Falsepositive diagnoses tend to increase the DCO index for given levels of incompleteness and given levels of case fatality rates. While this phenomenon occurs at all levels of Pd, the effects of false-positive diagnoses are somewhat more limited in size than the effects of false-negative diagnoses. As shown in Table I , false-negative and false-positive diagnoses typically occur in combination. In that case, their effects will partly cancel out, and their net effect will depend on the relative magnitude of both types of error. The present paper illustrates that the DCO index is a very poor indicator of incompleteness of cancer registration. The DCO index strongly depends on the case fatality rate and the misclassification rates of cancer deaths among unregistered patients. Case fatality rates and misclassification rates of cancer deaths show considerable variation between cancer sites among registered patients. They are typically unknown for unregistered patients. This seriously hinders reliable translation of the DCO index into an absolute measure of completeness in most instances. Nevertheless, the DCO index may be of some limited use as a relative measure, if comparing completeness of registration for malignancies with similar case fatality rates and similar levels of accuracy of cancer death certificates of unregistered patients.
For example, one might consider using the DCO index to rank completeness of cancer registration with respect to a specific type of cancer between cancer registries in populations with similar registration practices and similar case fatality rates. The DCO index should not be used, however, to compare completeness of cancer registration for different types of cancer within a registry, given the large variation in case fatality rates between cancers. Comparison of the DCO index for all forms of cancer between registries is also problematic if there is strong variation in the spectrum of cancer diagnoses. Similarly, uncritical use of the DCO index for monitoring completeness over time is discouraged if there are changes in case fatality rates. Since case fatality rates tend to decrease rather than increase over time in most countries, a constant DCO index would typically reflect decreasing rather than increasing completeness of cancer registration.
Variation in rates of false-positive and false-negative diagnoses of unregistered patients further distracts from the use of the DCO index for monitoring incompleteness of cancer registration between cancer registries or over time. The problem can be limited to some extent by combining cancer sites between which misclassification is common, such as colon and rectum cancer or cervical and endometrial cancer. Diagnostic misclassification is usually of minor concern if the focus is on all cancers rather than site-specific cancers.
An additional methodological issue not addressed in the present paper also requires careful consideration in the interpretation of the DCO index. There is usually a time lag of various length between cancer diagnosis and death from the cancer. This time lag can range between a few days and many years for various types of cancer. Nevertheless, the date of death is typically recorded as date of diagnosis for DCO cases. This imprecision may be negligible whenever there are no major temporal changes in the proportion of DCO cases, but may further reduce the value of the DCO index as an indicator of incompleteness otherwise. The problem is of particular concern during the first few years of operation of a new cancer registry, since there is typically a rapidly decreasing proportion of DCO cases whose cancer has been diagnosed before the beginning of registration.
The limitations of the DCO index underline the need for better approaches to assess incompleteness of cancer registration. A variety of alternative proposals to assess incompleteness of cancer registration has been made, a full discussion of which would be beyond the scope of this paper.
A commonly used index is the mortality/incidence ratio (Coleman and Demaret, 1988; Jensen et al., 1991; Parkin et al., 1992) . Obviously, this index shares the major limitation of the DCO index, the dependency on the case fatality rate and on the inaccuracy of death certificates.
The limitations of the DCO index outlined in the present paper equally apply to the DCO index (proportion of cases first notified by death certificates), which has been proposed as an alternative measure of incompleteness. The relation of the DCN index and incompleteness depends on case fatality rates and misclassification rates of cancer deaths among patients for whom no primary notification by sources other than the death certificate is made. For these patients, mis- classification rates of cancer deaths will typically be somewhat lower than for DCO cases though, since misdiagnoses can be corrected among those patients for whom a followback notification by other sources is obtained. The conceptually simplest and most definitive method to check completeness of cancer registration is to identify a series of cases from an independent source, e.g. lists of probands in clinical trials or other research studies, and to assess how many have been registered (Goldberg et al., 1980; Nwene and Smith, 1982; Mattson et al., 1985; Hunt and Coleman, 1987; Villard-Mackintosh et al., 1988; Swerdlow et al., 1993; Schouten et al., 1993) . Such independent lists are often unavailable, however. Therefore, this approach can rarely be employed for routine comparisons of completeness of registration between registries.
Recently, capture-recapture methods have attracted much interest as yet another approach to estimate completeness of disease monitoring (Wittes et al., 1974; Robles et al., 1988; Hilsenbeck et al., 1992; McCarty et al., 1993; Brenner, 1995; Brenner et al., 1995) . The principle is to estimate the number of missed cases by the degree of overlap between multiple incomplete sources of case ascertainment. Although it is still too early for definitive judgement, this methodology appears to be promising and should be further developed.
